Skip to main content
. 2017 Sep 12;2017:8685638. doi: 10.1155/2017/8685638

Figure 2.

Figure 2

Waterfall plots showing change in 2-dimensional tumor measurements according to WHO criteria after 4 cycles (2 cycles ifosfamide and doxorubicin, IA, and 2 cycles of ifosfamide and etoposide, IE, upper panels) and 2 cycles (IA, lower panels). On all four panels patients are arranged by best response measured after cycle 4. Patients removed from treatment after cycle 2. Target lesion stable, but progressive disease with new lesion.